Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes

Tri Juli Edi Tarigan,1 Adisti Dwijayanti,2 Susie Setyowati,3 Melva Louisa4 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; 2Department of Medical Pharmacy, F...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tarigan TJE, Dwijayanti A, Setyowati S, Louisa M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2021-01-01
coleção:	Diabetes, Metabolic Syndrome and Obesity
Assuntos:	biosimilar insulin autoantibody zinc transporter 8 antibody hyperglycemia
Acesso em linha:	https://www.dovepress.com/immunogenicity-and-efficacy-of-insulin-glargine-biosimilar-ezelin-vers-peer-reviewed-article-DMSO
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!